The GI-Neu project, funded by the 7th Framework Programme of the European Commission, created a multiannual joint programme of collaboration between research-intensive non-commercial and commercial organisations to increase knowledge on the effects of colostrum-based neutraceuticals on FGID. The vast majority of attempts to address FGID to date have been led by either the public or the private sector alone. The GI-Neu project was designed to exploit the complimentary expertise of non-commercial and commercial organisations through knowledge sharing and transfer between sectors. This was achieved by staff secondments of researchers from outside the partnership for the purpose of networking, training activities, workshops, and joint research. Through these activities, the GI-Neu project has fostered mutual understanding of the different cultural settings and skill requirements of the non-commercial and commercial sectors, encouraging entrepreneurship and long-term intersectoral collaboration regarding the effects of colostrum-based neutraceuticals on FGID. Eventually, the aim of this partnership was to translate creative ideas into innovative products and process